The top ACC news stories of 2018 include new ACC/AHA guidelines on cholesterol and bradycardia, health policy news from the Centers for Medicaid and Medicare Services (CMS), the hottest trials from ACC.18, and more.

Here is a list of the top ACC.org news stories in 2018:

1. ODYSSEY Outcomes: Results Suggest Use of PCSK9 Inhibitor Reduces CV Events, LDL-C in ACS Patients
• Full ACC.18 Coverage
2. New ACC/AHA Cholesterol Guideline Allows For More Personalized Care; New Treatment Options
• ACC Cholesterol Guideline Hub
3. CVD-REAL 2: SGLT-2 Inhibitors Associated With Lower CV Risk vs. Other Glucose-Lowering Drugs
• Full ACC.18 Coverage
4. Is Caffeine Safe, Protective For Patients With AFib, Arrhythmias?
5. Does Aspirin as a Primary Prevention Strategy Reduce CV Events?
6. CMS Releases Final Coverage Policy For ICD Implantation
7. CARES: Increased Risk of Death With Febuxostat in Patients With Gout and CV Disease
• Full ACC.18 Coverage
8. ANNEXA-4 Suggests Experimental Drug Controls Bleeding in Patients Taking Factor Xa Inhibitors
• Full ACC.18 Coverage
9. New Guideline Outlines Recommendations For Evaluating, Managing Bradycardia
• ACC Bradycardia Guideline Hub
10. CMS Releases Final 2019 Physician Fee Schedule

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiovascular Care Team, Dyslipidemia, Prevention, Implantable Devices, Lipid Metabolism, Nonstatins

Keywords: Medicaid, Caffeine, Aspirin, Factor Xa Inhibitors, Bradycardia, Glucose, Centers for Medicare and Medicaid Services, U.S., Cholesterol, Medicare, Primary Prevention, Fee Schedules, Health Policy

< Back to Listings